CCN5 and breast adenocarcinoma: The TSP1 domain of CCN5 also recapitulated a positive regulatory function previously assigned to full-length CCN5, that is, induction of ER-α expression in triple negative MDA-MB-231 mammary adenocarcinoma cells.